39 studies found for:    defend
Show Display Options
Rank Status Study
1 Completed Trial of Otelixizumab for Adults With Newly Diagnosed Type 1 Diabetes Mellitus (Autoimmune): DEFEND-1
Condition: Diabetes Mellitus, Type 1
Interventions: Biological: otelixizumab infusion plus physician determined standard of care;   Biological: placebo infusion plus physician determined standard of care
2 Completed Letrozole in the Treatment of Advanced or Recurrent Hormone Receptor Positive Endometrial Cancer
Condition: Endometrial Cancer
Intervention: Drug: Letrozole
3 Completed Trial of Otelixizumab for Adolescents and Adults With Newly Diagnosed Type 1 Diabetes Mellitus (Autoimmune): DEFEND-2
Condition: Diabetes Mellitus, Type 1
Interventions: Biological: Otelixizumab;   Biological: Placebo
4 Terminated Safety and Efficacy Study to Evaluate the Effect of SLV320 on Renal Function in Patients With Worsening Heart Failure
Condition: Acute Decompensated Heart Failure; Renal Dysfunction
Interventions: Drug: SLV320;   Drug: Placebo
5 Completed Metabolic Adaptation to Diabetes
Condition: Type 2 Diabetes
Intervention: Procedure: glucose clamp
6 Unknown  Hypoglycemia Associated Autonomic Failure in Type 1 DM, Q2
Condition: Type 1 Diabetes
Interventions: Drug: Alprazolam;   Other: control group
7 Recruiting Mechanisms of Hypoglycemia Associated Autonomic Dysfunction, Q4-Atomoxetine
Condition: Type 1 Diabetes
Interventions: Drug: Atomoxetine;   Drug: Placebo
8 Recruiting Mechanisms of Hypoglycemia Associated Autonomic Dysfunction Question 2
Condition: Type 1 Diabetes
Interventions: Drug: Alprazolam;   Drug: Placebo
9 Completed Peer Interactions and Food Are Substitutable in Youth
Conditions: Activity Choices;   Caloric Intake;   Social Time
Intervention:
10 Recruiting Investigation of Immune Disorders and Deficiencies
Conditions: Primary Immune Deficiencies;   Autoimmune Diseases;   Inflammatory Diseases;   Common Variable Immune Deficiencies;   Hypogammaglobulinemia
Intervention:
11 Completed Trial of Vascular Endothelial Growth Factor (VEGF), Bevacizumab, in Combination With Cytotoxic Chemotherapy for Endometrial Cancer
Condition: Endometrial Carcinoma
Intervention: Drug: carboplatin, paclitaxel, and bevacizumab
12 Recruiting Detection and Characterization of Infections and Infection Susceptibility
Conditions: Immune Disorders;   Chronic Granulomatous Disease;   Genetic Immunological Deficiencies;   Hyperimmunoglobulin-E Recurrent Infection Syndrome;   Recurrent Infections
Intervention:
13 Active, not recruiting Comparison Between Single and Triple Rubber Band Ligation for the Treatment of Hemorrhoids
Condition: Second-degree Hemorrhoids
Interventions: Procedure: Single hemorrhoidal ligation;   Procedure: Triple hemorrhoidal ligation
14 Active, not recruiting Glutamine Supplementation in Cystic Fibrosis
Conditions: Cystic Fibrosis;   Immune Function
Interventions: Dietary Supplement: Glutamine;   Dietary Supplement: L-alanine
15 Completed Safety and Effectiveness of CD4-IgG2 in HIV-Positive Children
Condition: HIV Infections
Intervention: Drug: CD4-IgG2
16 Active, not recruiting The Natural History of Gene Expression in the Lung Cells of Non-Smokers, Smokers and Ex-Smokers in Health and Disease
Conditions: Chronic Obstructive Pulmonary Disease (COPD);   Smoking;   Smoking Cessation;   Healthy Smoker;   Smoker;   Chronic Bronchitis;   Emphysema
Intervention:
17 Completed Visilizumab for Moderate to Severe Inflammatory, Nonstricturing, Nonpenetrating Crohn's Disease
Condition: Crohn's Disease
Intervention: Drug: Visilizumab
18 Completed Visilizumab for Treatment of Perianal Fistulas in Crohn's Disease
Condition: Crohn's Disease
Intervention: Drug: Visilizumab
19 Active, not recruiting Comparison of Therapeutic Regimens for Scleroderma Interstitial Lung Disease (The Scleroderma Lung Study II)
Conditions: Scleroderma;   Interstitial Lung Disease
Interventions: Drug: Mycophenolate mofetil;   Drug: Cyclophosphamide;   Drug: Placebo
20 Unknown  Following Lipectomy to Understand Adipose Tissue Re-accumulation
Conditions: Menopause;   Pre-menopause
Intervention: Procedure: Femoral lipectomy

Previous Page Studies Shown (1-20) Next Page (21-39) Show next page of results
Indicates status has not been verified in more than two years